Related Experiment Video

Updated: Jun 6, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38

Maren Bakkebø1, Kanutte Huse, Vera I Hilden

  • 1Department of Immunology, Institute for Cancer Research, Oslo University Hospital Montebello, Oslo, Norway.

BMC Immunology
|November 25, 2010
PubMed
Abstract

Insights

Transforming growth factor β (TGF-β) resistance in B-cell lymphoma involves Smad1/5 phosphorylation and p38 MAPK signaling. Activin receptor-like kinase 5 (Alk-5) expression is crucial for TGF-β anti-proliferative effects.

Area of Science:

  • Cell biology
  • Molecular oncology
  • Signal transduction

Background:

  • Transforming growth factor β (TGF-β) superfamily cytokines regulate cell proliferation, apoptosis, and differentiation.
  • Cancer cells often develop resistance to TGF-β's anti-proliferative signals, frequently due to mutations in signaling pathway proteins.

Purpose of the Study:

  • To investigate TGF-β signaling differences between B-cell lymphoma cell lines sensitive and resistant to TGF-β-induced anti-proliferation.
  • To identify key molecular players involved in TGF-β resistance in B-cell lymphoma.

Main Methods:

  • Comparative analysis of TGF-β receptor expression (e.g., Alk-5) in sensitive and resistant B-cell lymphoma lines.
  • Assessment of Smad2 and Smad1/5 phosphorylation in response to TGF-β and activin A.
  • Evaluation of TGF-β target gene expression (Id1, Pai-1) and p38 MAPK phosphorylation.
  • Functional studies involving p38 MAPK inhibition.

Main Results:

  • TGF-β sensitive cell lines exhibited higher cell surface expression of activin receptor-like kinase 5 (Alk-5).
  • Smad1/5 phosphorylation was observed exclusively in TGF-β sensitive cells, while Smad2 phosphorylation was similar in both groups.
  • Up-regulation of TGF-β target genes (Id1, Pai-1) and constitutive p38 MAPK phosphorylation were restricted to sensitive cell lines.
  • Inhibition of p38 MAPK reduced sensitivity to TGF-β.

Conclusions:

  • Smad1/5 phosphorylation is critical for the anti-proliferative action of TGF-β in B-cell lymphoma.
  • High Alk-5 expression in sensitive cells may facilitate Smad1/5 signaling.
  • p38 MAPK plays a regulatory role in TGF-β-induced anti-proliferative effects in B-cell lymphoma.

More Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation09:40

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation

Published on: June 27, 2017

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...